Tracking drugs after they’ve left the manufacturer has traditionally been an afterthought. Pharmaceutical companies now want to use downstream post-delivery data to improve their products and ensure quality. Healthcare regulators would like to see better management of drugs throughout the entire drug life cycle. Identifying counterfeit drugs is a huge global challenge and the pharma industry is still struggling to find a trustworthy solution. In this episode, Darryl Glover (Chief Clinical Officer, iSolve) shares his insight on how their project, BlockRx , can help certify provenance of drugs using permissioned/private blockchains with Intel’s Hyperledger Sawtooth and Microsoft’s Coco Framework.
Guest email:
[email protected]
https://www.blockrx.com/
Health Unchained New Corner: https://www.bloomberg.com/news/articles/2018-04-30/can-blockchain-fix-the-opioid-epidemic-intel-wants-to-find-out